Skip to content
healthcare.dev

NURTEC ODT

NDC 72618-3000, rimegepant sulfate, tablet, orally disintegrating, from Pfizer Laboratories Div Pfizer Inc.

Product NDC
72618-3000
Status
Listed
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA212728
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72618-3000 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIMEGEPANT SULFATE75 mg/1

Pharmacologic classes

Calcitonin Gene-related Peptide Receptor Antagonist [EPC]; Calcitonin Gene-related Peptide Receptor Antagonists [MoA]

Package NDCNDC-11Package
72618-3000-2726183000021 BLISTER PACK in 1 CARTON (72618-3000-2) / 8 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9ef08e09-1098-35cc-e053-2a95a90a3e1d
  • NADAC price for package 72618300002

    GET /v1/drugs/nadac/72618300002

Use it

Look up 72618-3000 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72618-3000 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72618-3000. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.